Table 2.
Baseline and Post-treatment Ratings for TAPS and Waiting-list Control
| Baseline | Post-Treatment | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAPS (n = 20) | WL (n = 20) | TAPS (n = 20) | WL (n = 19) | ||||||||
| Variable | n | (%) | n | (%) | n | (%) | n | (%) | χ2 or F(df)a | ||
| Principal anxiety disorderb (present) | 20 | (100) | 20 | (100) | 11 | (55) | 19 | (100) | 11.1 | (1)** | |
| Treatment responderc | |||||||||||
| CGI-I | -- | -- | -- | -- | 16 | (80) | 0 | (0) | 25.8 | (1)** | |
|
| |||||||||||
| (n = 20) | (n | = 20) | (n = 20) | (n = 17) | |||||||
|
| |||||||||||
| M | (SD) | M | (SD) | Md | (SE) | Md | (SE) | Effect size | |||
|
| |||||||||||
| Principal diagnosis CSR (0–8) | 6.2 | (1.0) | 5.3 | (.8) | 3.3 | (.3) | 5.6 | (.3) | 23.7 | (1, 36)** | 3.2 |
| Self-ratings | |||||||||||
| Pain (0–8) | 3.6 | (2.0) | 3.9 | (2.2) | 1.6 | (.4) | 3.9 | (.4) | 16.3 | (1, 34)** | 1.0 |
| GI-CSI (0–24) | 8.7 | (5.5) | 8.7 | (6.2) | 4.5 | (.8) | 7.1 | (.8) | 5.3 | (1, 34)* | .6 |
| Parent ratings | |||||||||||
| Pain (0–8) | 4.3 | (2.0) | 4.5 | (1.9) | 2.3 | (.4) | 4.0 | (.4) | 8.8 | (1, 34)* | .8 |
| Independent evaluator ratings | |||||||||||
| CGAS (1–100) | 55.2 | (9.1) | 54.8 | (10.0) | 67.2 | (2.1) | 57.1 | (2.1) | 11.9 | (1, 36)** | 1.0 |
Note. TAPS = Treatment of Anxiety and Physical Symptoms program group. WL = waiting-list control group. Clinical Global Impressions – Improvement – Independent Evaluator. GI-CSI = Gastrointestinal Factor of Children’s Somatization Inventory. CGAS = Children’s Global Assessment Scale.
a
Post-treatment completer analyses.
b
Principal anxiety disorder present based on ADIS rating of 4 or above.
c
Responder: Clinical Global Impression Scale (CGI-I) ratings of 1, 2, or 3.
d
Post-treatment means adjusted for baseline values.
*
p < .05.
**
p < .001.